Epigenetic Therapy in Human Choriocarcinoma
Because epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and promotion of tumorigenesis in choriocarcinomas, novel compounds endowed with a histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. HDAC inhibitors (HDACIs) we...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
MDPI
2010
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837331/ |